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Mutations in FYCO1 Cause
Autosomal-Recessive Congenital Cataracts
Jianjun Chen,1,9 Zhiwei Ma,1,9 Xiaodong Jiao,1 Robert Fariss,2 Wanda Lee Kantorow,3 Marc Kantorow,3
Eran Pras,4 Moshe Frydman,5 Elon Pras,5 Sheikh Riazuddin,6,7 S. Amer Riazuddin,6,8,10
and J. Fielding Hejtmancik1,10,*
Congenital cataracts (CCs), responsible for about one-third of blindness in infants, are amajor cause of vision loss in childrenworldwide.
Autosomal-recessive congenital cataracts (arCC) form a clinically diverse and genetically heterogeneous group of disorders of the crys-
talline lens. To identify the genetic cause of arCC in consanguineous Pakistani families, we performed genome-wide linkage analysis and
fine mapping and identified linkage to 3p21-p22 with a summed LOD score of 33.42. Mutations in the gene encoding FYVE and coiled-
coil domain containing 1 (FYCO1), a PI(3)P-binding protein family member that is associated with the exterior of autophagosomes and
mediates microtubule plus-end-directed vesicle transport, were identified in 12 Pakistani families and one Arab Israeli family in which
arCC had previously been mapped to the overlapping CATC2 region. Nine different mutations were identified, including c.3755 delC
(p.Ala1252AspfsX71), c.3858_3862dupGGAAT (p.Leu1288TrpfsX37), c.1045 C>T (p.Gln349X), c.2206C>T (p.Gln736X), c.2761C>T
(p.Arg921X), c.2830C>T (p.Arg944X), c.3150þ1 G>T, c.4127T>C (p.Leu1376Pro), and c.1546C>T (p.Gln516X). Fyco1 is expressed
in the mouse embryonic and adult lens and peaks at P12d. Expressedmutant proteins p.Leu1288TrpfsX37 and p.Gln736X are truncated
on immunoblots. Wild-type and p.L1376P FYCO1, the only missense mutant identified, migrate at the expected molecular mass. Both
wild-type and p. Leu1376Pro FYCO1 proteins expressed in human lens epithelial cells partially colocalize to microtubules and are found
adjacent to Golgi, but they primarily colocalize to autophagosomes. Thus, FYCO1 is involved in lens development and transparency in
humans, and mutations in this gene are one of the most common causes of arCC in the Pakistani population.A significant cause of vision loss worldwide, congenital
cataracts (CC) cause approximately one-third of the cases
of blindness in infants.1 They can occur in an isolated
fashion or as one component of a syndrome affecting
multiple tissues, although the distinction might be some-
what arbitrary in some cases. In approximately 70% of CC
cases, the lens alone is involved.2 Nonsyndromic CCs
have an estimated frequency of 1–6 per 10,000 live
births,3 and approximately one-third of CC cases are
familial.4 Congenital cataracts are very heterogeneous,
both clinically and genetically, and approximately 8.3%–
25% of nonsyndromic CCs are inherited as an autosomal-
recessive (ar), autosomal-dominant (ad), or X-linked
trait.5–7 To date, more than 40 loci for human CCs have
been identified, and more than 26 of them have been asso-
ciated with causative mutations in specific genes.8 To date,
14 genetic loci have been implicated in nonsyndromic
autosomal-recessive CC (arCC), and most of these account
for a few percentage points of CC cases each. Among these
loci, mutations in nine genes, eph-receptor type-A2
(EPHA2, MIM 613020), connexin50 (GJA8, MIM 600897),
glucosaminyl (N-acetyl) transferase 2 (GCNT2, MIM
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The Ame602438), lens intrinsic membrane protein (LIM2, MIM,
154045), beaded filament structural protein 1 (BFSP1,
MIM 603307), aA-crystallin (CRYAA, MIM 123580), bB1-
crystallin (CRYBB1, MIM 600929), and bB3-crystallin
(CRYBB3, MIM 123630), have been found.9–18 In six of
the 14 reported arCC loci, the mutated gene is as yet
unknown. The CATC2 (Cataract, Autosomal Recessive
Congenital 2, MIM 610019) locus was first mapped to
chromosome 3 in three inbred Arab families in 2001, but
the disease-associated variants previously had not been
identified.19
As part of anongoing collaborationbetween theNational
Eye Institute (NEI, Bethesda,MD,USA), theNationalCentre
of Excellence in Molecular Biology (NCEMB, Lahore,
Pakistan), and Allama Iqbal Medical College (Lahore,
Pakistan), a locus for arCC in twelve Pakistani families
has been mapped to chromosomal region 3p21-p22, over-
lapping the CATC2 locus.19 Subsequently, homozygous
missense, splice site, nonsense, and frameshift mutations
have been identified in a positional candidate gene,
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Figure 1. Slit-Lamp Photograph of a Cataract Patient with
FYCO1 Mutations
A slit-lamp photograph of affected individual 19 of family 060069
shows a nuclear cataract that developed in early infancy.mapped. In total, 9 FYCO1mutations were identified in 13
arCC families, including 44 affected individuals, in which
arCC segregates with themutant FYCO1 allele, underlining
the importance of FYCO1 in both lensbiology and thepath-
ogenesis of arCC.
In this study, genome-wide linkage scans and fine
mapping were performed in eight unrelated consanguin-
eous arCC families of Pakistani origin, and 63 additional
unlinked consanguineous families of Pakistani origin were
additionally screened for mutations in FYCO1. Families
described in this study include 060003 (also referred to
as PKCC003), 060012 (PKCC012), 060014 (PKCC014),
060031 (PKCC031), 060041 (PKCC041), 060044
(PKCC044), 060054 (PKCC054), 060058 (PKCC058),
060064 (PKCC064), 060069 (PKCC069), 060091
(PKCC091), and 060094 (PKCC094). This study was
approved by Institutional Review Board (IRB) of the
National Centre of Excellence in Molecular Biology and
the CNS IRB at the National Institutes of Health. Partici-
pating subjects gave informed consent consistent with
the tenets of theDeclaration ofHelsinki.Ophthalmological
examinations were performed at the Layton Rahmatullah
Benevolent Trust Hospital, Lahore, Pakistan. A detailed
medical history was obtained by interviewing family
members. Medical records of clinical exams conducted
with slit lamp biomicroscopy reported the types of cataract
in affected individuals of the twelve families. We also
recruited 150 unrelated, ethnically matched individuals,
who provided control DNA samples. Blood samples were
obtained from study participants and DNA was extracted
using standard inorganic methods as previously
described.20 All affected individuals available for examina-
tion from twelve consanguineous Pakistani arCC families
(060003, 060012, 060014, 060031, 060041, 060044,
060054, 060058, 060064, 060069, 060091, and 060094)
displayedbilateral nuclear cataracts that eitherwere present
at birth or developed in infancy (Figure 1). Some affected
individuals had undergone cataract surgery in the early
years of life, andhencenopictures of their lenseswere avail-
able. Autosomal recessive inheritance of the cataracts was
seen in all families (Figure 2A). No other ocular or systemic
abnormalities were present in these families.
Genome-wide linkage analysis was completed with 382
highly polymorphic microsatellite markers from the ABI
PRISM Linkage Mapping Set MD-10 (Figure S2, available
online; average spacing 10 cM; Applied Biosystems, Foster
City, CA). PCR products were separated on an ABI 3130
DNA Analyzer, and alleles were assigned with GeneMapper
Software version 4.0 (Applied Biosystems). Two-point link-
age analyses were performed with the FASTLINK version
of MLINK from the LINKAGE Program Package.21,22
Maximum LOD scores were calculated with ILINK. Auto-
somal-recessive cataracts were analyzed as a fully penetrant
traitwith adisease allele frequencyof 0.001, andequal allele
frequencies were arbitrarily used for all markers in
the genome-wide scan. Marker allele frequencies were
calculated from 100 Pakistani control individuals for fine828 The American Journal of Human Genetics 88, 827–838, June 10,mapping (Table S3). The marker order and distances
between the markers were obtained from the Marshfield
database and the NCBI chromosome 3 sequence maps
(see Table S1). Eight of these families (060003, 060012,
060041, 060058, 060064, 060069, 060091, and 060094)
independently showed significant or suggestive linkage to
chromosomal region 3p21-p22; LOD scores were 3.85,
2.52, 4.09, 2.36, 3.89, 5.62, 4.88, and 3.82, respectively.
Sequencing of candidate genes (see below) identified
FYCO1mutations in affected members of these eight fami-
lies and subsequently in four additional arCC families (see
below). Two-point linkage analysis in the 12 families with
FYCO1 mutations confirms linkage to a 7.4 cM (15.6 Mb)
region flanked by D3S3521 and D3S1289 (Table 1). The
linked region includes markers D3S3582 (Zmax ¼ 33.4 at
q ¼ 0), D3S3561 (Zmax ¼ 22.4 at q ¼ 0), D3S3685 (Zmax ¼
33.5 at q ¼ 0.01), and D3S2407 (Zmax ¼ 24 at q ¼ 0.03).
Significant LOD scores were also seen with other markers
in the region, including D3S3512 (Zmax ¼ 16.75 at q ¼
0.08), D3S3521 (Zmax ¼ 18.15 at q ¼ 0.05), D3S1289
(Zmax ¼ 25.86 at q ¼ 0.02), D3S3616 (Zmax ¼ 20.14 at q ¼
0.05), D3S1300 (Zmax ¼ 14.29 at q ¼ 0.09), and D3S3698
(Zmax ¼ 2.14 at q ¼ 0.2), although these markers show
obligate recombination events. Haplotype analysis con-
firmed and narrowed the critical interval (Figure 2B and
Figure S1). Key recombination events were detected
between markers D3S3582 and the adjacent telomeric
marker D3S3685 in affected individuals 22, 26, 28, and
30 of family 060091 (Figure 2B and Figure S1), so that
D3S3685 defines the telomeric boundary for the 3.5 cM
(12 Mb) disease interval. Similarly, recombination events
were detected between marker D3S3561 and its adjacent
centromeric marker D3S1289 in individual 14 of family
060041, individuals 3, 7, and 8 of family 060064, and indi-
vidual 26 of 060094 (Figure 2B and Figure S1), so that
D3S1289 is the centromeric flanking marker. Thus, arCC
in each of these 12 families cosegregates with a chromo-
some 3 region that includes FYCO1.2011
Figure 2. Pedigrees and Linkage Intervals for arCC Families
(A) Twelve arCC pedigrees collected from Pakistan. Filled symbols denote affected individuals. Eight pedigrees (060003, 060012, 060041,
060058, 060064, 060069, 060091, and 060094) were used for genome-wide linkage scans and finemapping of arCC intervals and candi-
date-genemutation screenings. Four pedigrees (060014, 060031, 060044, and 060054) were used for finemapping of arCC intervals and
candidate-gene mutation screenings. Individuals who were genotyped are marked with an asterisk.
(B) Refined arCC interval on the basis of haplotype analysis of patients with recombination events. Markers with the homozygous geno-
type are boxed so that the region without recombination is defined. Alleles for markers D3S3685 and D3S1289 in patients with recom-
bination events are in bold so that the telomeric and centromeric breakpoints, respectively, are shown. The disease interval was placed
between markers D3S3685 and D3S1289.
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Table 1. Two-Point LOD Scores of Markers on Chromosomal Region 3p21 in a Total of 12 arCC Families
Marker cM Mb 0 0.01 0.05 0.1 0.2 0.3 0.4 Zmax qmax
D3S3512 61.52 34.59 - N 12.29 16.28 16.64 13.85 9.42 4.56 16.75 0.08
D3S3521 63.12 38.87 - N 15.69 18.15 17.21 13.1 8.2 3.5 18.15 0.05
D3S2407 67.94 41.39 16.94 23.58 23.63 21.72 16.55 10.74 4.98 24.02 0.03
D3S3685 67.94 42.47 32.7 33.5 31.4 28.09 20.87 13.32 6.07 33.5 0.01
D3S3582 69.19 45.39 33.42 32.77 30.14 26.74 19.63 12.36 5.54 33.42 0
D3S3561 70.61 52.34 22.37 21.88 19.9 17.4 12.35 7.43 3.09 22.37 0
D3S1289* 71.41 54.48 - N 25.62 25.05 22.56 16.45 9.93 3.99 25.86 0.02
D3S3616 76.48 57.34 - N 17.11 20.14 19.28 14.79 9.15 3.94 20.14 0.05
D3S1300* 80.32 60.51 - N 7.01 13.46 14.25 11. 8 7.75 3.54 14.29 0.09
D3S3698 84.92 63.12 - N 17.66 4.57 0.21 2.14 1.93 0.99 2.14 0.2
An asterisk indicates that an STR marker was included in the genome-wide scan.The linked region on chromosome 3 contains 287 genes
or potential genes, according to the UCSC database. Candi-
date genes were prioritized on the basis of their expression
in the lens and possible function in lens biology and trans-
parency, as indicated in the NCBI and GeneCard databases.
Although no candidate genes were absolutely excluded,
pseudogenes, genes of unknown function and without
known domain structures, and genes not expressed in
the lens were given the lowest priorities. Primer pairs for
individual exons in the critical interval were designed
with the online primer3 program. The sequences and
amplification conditions for FYCO1 primers are available
in Table S2. The PCR primers for each exon were used for
bidirectional sequencing with Big Dye Terminator Ready
reactionmix according to instructions of the manufacturerTable 2. FYCO1 Mutations in 13 arCC Families
Family Allele Sharing Maximum LOD Score Exon
060064 no 3.89 8
060003 yes 3.85 8
060012 yes 2.52 8
060069 yes 5.62 8
060054 no 2.61 8
060041 no 4.09 8
060044 no 2.53 9
060091 no 4.88 13
060094 yes 3.82 14
060014 yes 2.73 14
060058 yes 2.36 16
060031 yes 2.28 16
Family 119 no n/a 8
Nucleotide and amino acid designations are based on Refseq NM_024513.2.
a These C>T changes occurred in a CpG dinucleotide.
830 The American Journal of Human Genetics 88, 827–838, June 10,(Applied Biosystems, Foster City, CA). Sequencing was per-
formed on an ABI PRISM 3130 automated sequencer
(Applied Biosystems, Foster City, CA). Sequence traces
were analyzed with Mutation Surveyor (Soft Genetics
Inc., State College PA) and the Seqman program of DNAS-
TAR Software (DNASTAR Inc, Madison, WI, USA).
After family060064was screenedfor35genes inthe linked
region (all of these genes were found to lack pathogenic
mutations), the FYVE and coiled-coil domain containing 1
(FYCO1) genewas sequenced, andmutationswere identified
in this family and subsequently in the remaining seven
linked families (NM_024513.2, Table 2 and Figure 3). Muta-
tions were confirmed in all available affected family
members. In family 060064, the affected individuals carry a
homozygous C>T transition (1045 C>T) in exon 8, whichNucleotide Change Predicted Amino Acid Change
c.1045 C>T p.Gln349X
c.2206C>T p.Gln736X
c.2206C>T p.Gln736X
c.2206C>T p.Gln736X
c.2761C>Ta p.Arg921X
c.2830C>Ta p.Arg944X
c.3150þ1 G>T inactivation of splice donor site
c.3755 delC p.Ala1252AspfsX71
c.3858_3862dupGGAAT p.Leu1288TrpfsX37
c.3858_3862dupGGAAT p.Leu1288TrpfsX37
c.4127T>C p.Leu1376Pro
c.4127T>C p.Leu1376Pro
c.1546C>T p.Gln516X
2011
Figure 3. Sequence Electropherograms of the
Eight Homozygous Mutations Found in FYCO1
and Associated with arCC
Wild-type sequence from normal control individ-
uals is shown in the top panel for compari-
son. The c.1045C>T (p.Gln349X), c.1546C>T
(p.Gln516X)), c.2206C>T (p.Gln736X), c.2761C>
T (p. Arg921X), and c.2830C>T (p. Arg944X)
mutations result in the generation of a stop
codon; the c.3755 delC (Ala1252AspfsX71) and
c.3858_3862dupGGAAT (p.Leu1288TrpfsX37)
mutations lead to a frameshift and a premature
termination of translation; the c. 3150þ1 G>T
mutation leads to elimination of the intron 9
donor site; and the c.4127T>C (p.Leu1376Pro)
mutation results in the change of a leucine residue
to a proline residue in exon 16.results in a premature termination of translation
(p.Gln349X). Three families (060003, 060012, and 060069)
share a homozygous C>T transition (2206 C>T) in exon 8,The American Journal of Hand this transition results in a putative
premature termination of translation or
nonsense-mediated decay (p.Gln736X).
These families share a common haplotype
of 14 consecutive SNP markers across
FYCO1, suggesting that they derive the
mutant allele from a common ancestor
(Table 3). In family 060041, a homozygous
single base change in exon 8 converts
an arginine residue to a premature stop
codon (c.2830C>T; p.Arg944X). In family
060091, a homozygous single base-pair
deletion in exon 13 causes a frameshift
(c.3755 delC, p.Ala1252AspfsX71) resulting
in a putative stop codon 71 amino
acidsdownstream. In family060094, affected
individuals carry a homozygous 5 bp exon
14 duplication causing a frameshift
(c.3858_3862dupGGAAT,p.Leu1288TrpfsX37)
and putative stop codon 37 amino acids
downstream. In family 060058, affected
individuals carry a homozygous single
base change converting a leucine to a
proline residue in exon 16 (c.4127T>C;
p.Leu1376Pro).
Linkage analysis in some of the 125 arCC
families ascertained had mapped loci to
regions other than 3p21-p22. Sequencing
FYCO1 in an affected individual from
each of the 63 families in whom linkage
analysis had not yielded a maximal LOD
score of 3 identified mutations in four addi-
tional families (Table 2 and Figure 3). In
family 060054, a homozygous single base
change in exon 8 converts an arginine resi-
due to a premature stop codon (c.2761C>T;
p.Arg921X). In family 060044, we identi-fied a homozygous single base change, a G-to-T transver-
sion located in the conserved intron 9 donor splice site
(c. 3150þ1 G>T), suggesting that it might affect splicing.uman Genetics 88, 827–838, June 10, 2011 831
Table 3. Intragenic FYCO1 Haplotypes of Families Sharing Common Mutations
p.Gln736X p.Leu1288TrpfsX37 p.Leu1376Pro
PCR
Amplicon Position SNP ID
Allele
(Frequency)
Family
060003
Family
060012
Family
060069
Family
060094
Family
060014
Family
060031
Family
060058
4 45961218 rs4682801 C(.07)/A(.93) A A A A A A A
5 45956851 rs751552 T(.71)/A(.29) T T T A A T T
6 45954545 rs41289622 A(.61)/C(.39) C C C A A A A
8A 45950077 rs4683158 G(.07)/A(.93) A A A A A A A
8A 45950007 rs13071283 A(.61)/G(.39) G G G A A A A
8B 45949864 rs3733100 G(.56)/C(.44) C C C C C G G
8C 45949487 rs33910087 C(.67)/T(.33) T T T C C C C
8E 45948790 rs3796375 C((.73)/T(.27) C C C T T C C
8G 45948087 rs13079869 C(.7)/T(.3) T T T C C C C
8H 45947825 rs71622515 AAC(.61)/GAA(.39) GAA GAA GAA AAC AAC AAC AAC
8H 45947702 rs1994490 A(.39)/G(.61) G G G G G A A
12 45940870 rs13069079 C(.61)/T(.39) T T T C C C C
14 45936761 rs1463680 C(.18)/T(.82) T T T T T T T
15 45917899 rs1873002 A(.16)/G(.84) G G G G G G G
Fia .00019 .00019 .00019 .000813 .000813 .00162 .00162
FHCHM
b 0.019 0.019 0.019 0.026 0.026 0.037 0.037
The PCR amplicon, as well as the SNP, its position in the Ref_Assembly Build 37.1, SNP ID, and allelic variants are shown. Haplotypes were constructed on the basis
of 14 consecutive intragenic single nucleotide polymorphisms (SNPs) within FYCO1.
a Fi: Frequency of the haplotype calculated on an assumption of independent inheritance of all SNP alleles estimated from 48 unrelated Pakistani controls.
b FHCHM: Frequency of the haplotype calculated from 48 unrelated Pakistani controls via the CHM algorithm as implemented in the Golden Helix SVS package.This is supported by the calculated splice-site scores of 7.6
for the normal splice site and 3.2 for the variant site, pre-
dicting that the c. 3150þ1G>Tchange leads to elimination
of the intron 9 donor site. As in family 060094, exon 14 of
affected individuals in family 060014 contains a homozy-
gous 5 bp duplication causing a frameshift. The families
share a common 14 intragenic FYCO1 SNP haplotype, sug-
gesting that the mutant allele originates from a common
ancestor (Table 3). As in family 060058, exon 16 of affected
individuals in family 060031 contains ahomozygous single
base change that converts a leucine residue to a proline
residue (c.4127T>C; p.Leu1376Pro). Once more, these
two families share a common 14 SNP intragenic FYCO1
haplotype, suggesting that the disease allele originates
from a common ancestor (Table 3). Each of the identified
mutations segregates with arCC in the families, and none
is present in the NCBI or Ensemble SNP databases. In addi-
tion, none of these eight mutations was detected in
300 unrelated, ethnically matched control chromosomes
or in HapMap samples of any ethnicity. In addition,
FYCO1 was sequenced in family 1 from Pras et al.,19 and
the finding of a homozygous c.1546C>T sequence change
(p.Gln516X) indicates that the FYCO1 mutation causes
the autosomal-recessive congenital cataracts in this
consanguineous Arabic family (Figure 3) and thus is the
gene mutated in CATC2.832 The American Journal of Human Genetics 88, 827–838, June 10,FYCO1 on chromosome 3 contains 18 exons comprising
79 Kb and encoding 1478 amino acids.23,24 The full-
length FYCO1 mRNA (NM_024513.2) encodes a 167 kDa
protein. FYCO1 has been highly conserved throughout
evolution (protein sequence identity between humans
and dogs after alignment via the CLUSTALW algorithm
is 81%; that between humans and cows is 81%, that
between humans and mice is 78%, that between humans
and platypuses is 66%, and that between humans and
zebrafish is 37%). Analyses using the Conserved Domain
Database25 and the COILS web server26 predict that
FYCO1 is a long coiled-coil protein similar to members
of two families of Rab effector proteins: RUN and FYVE
domain-containing proteins (RUFY1–4) and early endo-
some antigen 1 (EEA1).27 FYCO1 contains a long central
coiled-coil region flanked at the N terminus by an a-helical
RUN domain or a zinc finger domain and at the C
terminus by a FYVE domain (Figure 4A). Unique to
FYCO1 is the presence of a C-terminal extension in the
form of a GOLD (Golgi dynamics) domain and an unstruc-
tured loop region connecting the FYVE and GOLD
domains (Figure 4A). Most of the identified mutations
truncate the protein and are predicted to cause termina-
tion of the peptide chain before the GOLD domain struc-
ture is formed and so to result in loss of activity. In addi-
tion, these truncation mutations occur in internal exons,2011
Figure 4. FYCO1 Domain Structure and Mutations
(A) Schematic diagram of FYCO1, showing the locations and
effects of the recessive mutations. Domain structure of FYCO1.
FYVE represents the FYVE zinc-finger domain; LIR represents the
LC3-interacting region; and GOLD represents the Golgi dynamics
domain. Red arrows show the positions of the truncation muta-
tions associatedwith arCC, and the blue arrow shows themissense
mutation p.Leu1376Pro.
(B) Amino acid sequence alignment around the FYCO1 Leu1376
amino acid (asterisk) in eight species, ranging from humans to
zebrafish.making these mRNAs potential targets for nonsense-medi-
ated decay.
A single missense mutation, Leu1376Pro, was observed
in two families, 060031 and 060058. Occurrence in two
unrelated families, segregation with the disease in these
two families, and absence in ethnically matched control
samples strongly suggests that p.Leu1376Pro might be
causative rather than a benign variant. The p.Leu1376Pro
missense mutation disrupts a residue conserved from
humans to mouse (L1376) within the GOLD domain, sug-
gesting that it is critical for protein function (Figure 4B).
In addition, L1376 is conserved in various mammalian
species as divergent as cows, dogs, mice, rabbits, and
marmosets and shows only conservative changes to isoleu-
cine and valine in platypuses and zebrafish, respectively
(Figure 4B). The p.Leu1376Pro change was scored (1.79)
as ‘‘possibly damaging’’ for protein function with Poly-
Phen and as ‘‘not tolerated’’ by SIFT algorithms. Also, the
Blosum80 matrix score for this amino acid change indi-
cates that it is potentially damaging for protein function.
However, final confirmation of the causative role of this
mutation awaits functional assays.
FYCO1 is reported to be widely expressed, especially in
heart and skeletal muscle, skin, adipose tissue, and the
ovary24 but also in the eye (Unigene). However, the patternThe Ameof FYCO1 expression within the eye has not previously
been described. To confirm that candidate genes, including
Fyco1, are expressed in the lens, RNA was extracted from
lenses of wild-type (FVB\N strain) mice at the following
stages: E8.5, E12.5, E16.5, P1, P12, P18, P21, and P35.
Contamination of dissected lenses with adjacent tissue
was estimated to be less than 5% by visual examination.
Lens cDNA was made by RT-PCR with the SuperScriptTM
III First-Strand Synthesis System (Invitrogen, Carlsbad),
and direct PCR amplification of the cDNA was performed.
Expression of Fyco1 was tested by PCR analysis of lens full-
length cDNA with the use of one pair of gene-specific
primers, which amplify a 4317 bp product. The PCR
primers (forward, 50-ATGGCTTCTAGCAGCACTGAGA-30;
reverse, 50-CTATGGGAAATCGCTTCCATCG-30) are located
in exons 2 and 18, respectively. PCR Products were then
electrophoresed on a 1% agarose gel and visualized by
ethidium bromide staining. The ubiquitously expressed
Gapdhwas used as an amplification control. No alternative
splicing was detected by amplification across adjacent and
multiple exons (data not shown).
In order to characterize expression of Fyco1 in the eye
lens during development, we assessed levels of Fyco1
transcript expression in themouse eye lens by quantitative
RT-PCR of RNA and generated a 4317 bp product spanning
exons 2–18 of the mouse Fyco1 (Figure 5A). Quantitative
real-time PCR was performed with SYBR Green chemistry
in an ABI Prism 7900HT Sequence Detection System
(Applied Biosystems, Warrington, UK). The Fyco1 real-time
PCR primers were 50- GCACCAAGAGGCTATGACTTG-30
and 50- ACTACTCATGCTGGAGCTTCG-30, producing a
117 bp PCR amplicon. The Gapdh real-time PCR primers
were 50-GGTCATCCATGACAACTTTGG-30 and 50-GGATG
CAGGGATGATGTTCT-30, creating a 145 bp PCR ampli-
con. Quantitative (q) RT-PCR was performed, and the
data were analyzed according to the recommendations of
the manufacturer (QIAGEN). We averaged and normalized
results by dividing mean values of Fyco1 mRNA by mean
values for Gapdh, the endogenous reference gene. Relative
quantification analysis was performed with the compara-
tive CT (2
DDCT) method, for which Gapdh was used as an
endogenous control gene for PCR normalization concern-
ing the amount of RNA added to the reverse transcription
reactions. Standard deviations were calculated from three
independent experiments; each real-time PCR reaction
was performed four times so that data reproducibility
could be assessed. Relative to levels of the internal control
Gapdh, FYCO1 mRNA is expressed at E8.5, in the devel-
oping lens placode. It remains relatively stable until it
doubles between E12.5, at which time the lens vesicle
has been formed and the primary lens fibers have elon-
gated from the posterior wall to fill the lens vesicle, and
E16.5. During this time the anterior epithelial cells divide
and move to the lens equator, where they elongate and
differentiate to form the secondary lens fiber cells, whose
formation is associated with loss of organelles. Increasing
rapidly, FYCO1 expression then roughly doubles betweenrican Journal of Human Genetics 88, 827–838, June 10, 2011 833
Figure 5. FYCO1 Expression in the Lens and Human Lens Cell Culture
(A) RT-PCR amplification of Fyco1mRNA from P3Wmouse eye lens. RT (þ) and RT (–) denote controls with or without reverse transcrip-
tion, respectively. Lane 1, full-length Fyco1 transcript; lane 2, negative control for Fyco1 transcript; lane 3, Gapdh transcript; lane 4, nega-
tive control for Gapdh transcript. MWM stands for molecular-weight marker.
(B) Relative expression of Fyco1 in mouse eye lens tissues at various ages. Expression of Fyco1 was measured in lens tissues by qRT-PCR at
different time points during aging. Data represent the mean (5SD) on an arbitrary scale (y axis) representing expression relative to the
housekeeping gene Gapdh.
(C) Characterization of mutant and wild-type GFP-FYCO1 by immunoblot analysis. Lane 1, transfected wild-type FYCO1-GFP lysate;
lane 2, lysate transfected with mutant FYCO1-GFP (p.Leu1376Pro); lane 3, lysate transfected with mutant FYCO1-GFP
(p.Leu1288TrpfsX37); lane 4, lysate transfected with mutant FYCO1-GFP (p.Gln736X); lane 5, untransfected lysate. ‘‘M’’ indicates
molecular-weight positions of the SeeBlue2 Plus molecular-weight marker. Wild-type proteins migrate at the predicted molecular weight
of 197 kDa. Missensemutant proteins migrate at the predictedmolecular weight of 197 kDa. Duplicationmutant proteins migrate at the
predicted molecular weight of 165 kDa. Nonsense mutant proteins migrate at the predicted molecular weight of 105 kDa.E16.5 and P12 before gradually decreasing to levels similar
to those in early embryonic life (Figure 5B).
Wild-type and mutant human FYCO1-GFP fusion
proteins were analyzed by immunoblotting after transient
transfection of human lens epithelial cells with wild-type
and mutant FYCO1-GFP constructs. The cDNA encoding
the full-length wild-type FYCO1 was purchased from
Origene (ORF Clones). Full-length wild-type FYCO1
cDNA was cloned into the phCMV6-AC-GFP vector, and
a GFP tag was placed at the C-terminal end of the cDNA.
Single point mutations were introduced into human
FYCO1 with a QuickChangeTM site directed mutagenesis
kit (Stratagene, La Jolla, CA, USA). DNA sequences were
verified by sequencing. The cells were harvested 48 hr after
transfection. Washed cells were lysed with RIPA buffer.
Immunoblot analysis was performed with 10 mg reduced
proteins separated on 10% Bis-Tris gels (Invitrogen).
Wild-type and L1376P missense mutant GFP-FYCO1
proteins migrate with an approximate molecular weight
of 197 kDa (Figure 5C), consistent with the expected
molecular mass, although the doublet below the 197 kDa
band in the L1376P mutant transfected lanes might
represent a degradation product. Characterization of the
mutant proteins, p.Leu1288TrpfsX37 and p.Gln736X,
with sizes of 165 and 105 kDa, indicated that they were
truncated as predicted, (Figure 5C).
In order to localize normal and mutant human FYCO1
protein within the cell, we transfected cultured human
lens epithelial cells with pCMV6-AC-FYCO1-GFP and visu-
alized immunofluorescence with a Zeiss LSM 510 laser
scanning confocal microscope. Human lens epithelial cells
(FHL12428) were cultured in DMEM, supplemented with834 The American Journal of Human Genetics 88, 827–838, June 10,10% fetal bovine serum, 2 mM glutamine, 100 units/ml
penicillin, and 100 mg/ml streptomycin. They were trans-
fected in triplicate in four-well chamber slides (Glass
Chamber Slide System) with the full-length wild-type or
mutant FYCO1 constructs (plasmid pCMV6-AC-FYCO1-
GFP) via PolyJet (SignaGen Laboratories) according to the
manufacturer’s instructions. Cells were analyzed 12 hr
post-transfection. They were cultured in four-well chamber
slides for 12 hr incubation and then fixed in freshly
prepared 4% formaldehyde for 20 min, washed twice
with PBS, and incubated in blocking buffer (0.5% Tween-
20, 1% bovine serum albumin, and 1% goat serum in 13
PBS) overnight in 4C. The blocking buffer was removed,
and cells were incubated with primary antibodies: mouse
monoclonal anti-tubulin (Sigma-Aldrich), mouse mono-
clonal anti-golgin 97 (Invitrogen), and polyclonal rabbit
anti-LC3antibody (Thermo Scientific Pierce Antibodies)
diluted 1:2000, 1:50, and 1:100, respectively, in blocking
buffer for 1 hr at room temperature. After being washed
three times with PBS plus 0.05% Tween-20 (PBST), cells
were incubated for 1 hr at room temperature with a
second antibody, either Alexa Fluor 555 goat-anti rabbit
IgG or goat-anti mouse IgG (red) diluted in buffer (0.05%
Tween-20, 1% bovine serum albumin in 13 PBS). Lyso-
Tracker Red DND-99 antibody (Invitrogen, USA, 1:20000)
was incubated with live transfected cells for 20min accord-
ing to the manufacturer’s instructions. After being washed
twice with PBS, cells were fixed in 4% paraformaldehyde.
Finally, they were washed three times and covered with
Gel-Mount and a coverslip. Immunofluorescence was
visualized with a Zeiss LSM 700 laser scanning confocal
microscope.2011
Figure 6. Immunofluorescence Images Show-
ing Localization of Mutant and Wild-Type GFP-
FYCO1 Proteins in Human Lens Epithelial Cells
Human lens epithelial cells were transfected with
pCMV6-AC-FYCO1-GFP inwhichwild-type (B,D,
F, andH) or p.Leu1376Promutant FYCO1 (A,C, E,
and G) is fused in frame with GFP. Cells were
immunostained with organelle-specific anti-
bodies or dyes, including anti-tubulin (red,micro-
tubules) (A and B), anti-golgin 97 (red, Golgi) (C
and D), anti-LC3 (red, autophagosomes) (E and
F), and LysoTracker Red DND-99 dye (red, endo-
somes and lysosomes) (G and H). All cells were
stainedwith thenuclearmarkerDAPI (40, 6-diami-
dino-2-phenylindole, blue, nucleus). RþG repre-
sents overlay of red and green channels. RþGþB
depicts red, green, andblue (DAPI) channels. Scale
bars represent 20 mm. Both wild-type (WT) and
mutant (Mut) proteins partially colocalize adja-
cent to Golgi, autophagosomes, endosomes, and
lysosomes of the cytoplasmofhuman lens epithe-
lial cells. Wild-type Xpress-tagged FYCO1 shows
similar localization (I).Neither the wild-type nor mutant human FYCO1 coloc-
alizes with tubulin, a microtubule marker (Figures 6A and
6B). The heaviest concentration localizes adjacent to
the trans-Golgi compartment, as identified by golgin 97
(Figures 6C and 6D). There is faint colocalization with
LC3, a marker for autophagosomes (Figures 6E and 6F)
and heavy staining colocalizing with LysoTracker, a marker
for endosomes and lysosomes (Figures 6G and 6H). Inter-The American Journal of Hestingly, although LysoTracker appears
to stain the lysosomes homogeneously,
FYCO1-GFP appears to be localized to the
outer membranes of the lysosomes and to
surround the LysoTracker stained body in
a circle, consistent with the results of Pankiv
et al.29 This suggests that FYCO1 localizes to
the autophagosomes, endosomes, and lyso-
somes and also suggests that the p.L1376P
mutation does not affect localization of
FYCO1. To ensure that localization of
FYCO1-GFP was not affected by the prox-
imity of the GFP tag to the GOLD domain,
we cloned wild-type FYCO1 into into
pcDNA4/HisMax C between Kpn1 and
Not1, which has an Xpress tag before the
FYCO1 sequence, expressed it in human
lens epithelial cells, and detected it as above.
Localization of the Xpress-tagged FYCO1
wassimilar to thatof theGFP-taggedprotein,
although there might be a more even distri-
bution of lysosomal staining (Figure 6I).
The CATC2 locus was first mapped to
chromosome 3 in 2001 by Pras et al.,19
but the disease-associated variant had not
been identified. In this study, arCC in
twelve unrelated Pakistani families hasbeen mapped to a 3.5 cM (12 Mb) chromosomal region,
3p21, flanked by D3S3685 and D3S1289, which overlaps
with the CATC2 locus described by Pras et al.19 arCC in
these families and in family 1 from Pras et al.19 has been
associated with mutations in FYCO1, the gene encoding
a protein important for transport of autophagocytic vesi-
cles. In total, nine different FYCO1mutations were identi-
fied in 13 (12 Pakistani and one Arab Israeli) arCC familiesuman Genetics 88, 827–838, June 10, 2011 835
including 44 affected individuals, in all of which the
disease segregates with the mutant allele. As part of an
ongoing collaboration to study arCC in Pakistan, we
have studied 125 familial cases of arCC, and FYCO1 is
responsible for approximately 10% to the total genetic
load of congenital cataracts in our study, and possibly in
the Pakistani population as well, which would mean that
FYCO1 mutations are among the most common causes of
inherited congenital cataracts in the Pakistani population
as a whole. In addition, identification of a FYCO1mutation
in an Arab Israeli family indicates that disruption of this
gene is a cause of arCC in additional populations as well.
This will be further clarified as FYCO1 is screened in other
populations.
Autophagy is associated with a variety of disease
processes, including tumorigenesis, neurodegenerative
diseases, cardiomyopathy, Crohn disease, fatty liver, type
II diabetes, defense against intracellular pathogens,
antigen-presentation, and longevity.30–33 Among the
proteins and multimolecular complexes that contribute to
autophagosome formation are PI(3)-binding proteins, PI3-
phosphatases, Rabs, the Atg1/ULK1 protein-kinase com-
plex, the Vps34-Atg6/beclin1 class III PI3-kinase complex,
and the Atg12 and Atg8/LC3 conjugation systems. Soon
after an autophagosome forms, its outer membrane fuses
with lysosomes to form autolysosomes, a process requiring
Rab7.34,35 FYCO1 was independently identified as a Rab7
effector and aPI(3)P-bindingprotein andwas found to asso-
ciate with the exterior of autophagosomes via its FYVE
domain. Pankiv et al. have recently reported that depletion
of FYCO1 leads to perinuclear accumulation of residual
autophagosomes, and proposed a role for FYCO1 in teth-
ering autophagosomes to plus-end-directed microtubule
motor proteins to explain this phenotype. FYCO1 also
interacts preferentially with GTP-bound Rab7, the GTPase
implicated in autophagosome-lysosomal fusion, and Rab7
recruits FYCO1 to autophagosomes.29,36 This suggests
that FYCO1mediatesmicrotubule plus-end-directedmove-
ment of autophagosomes. In transfected human lens
epithelial cells, FYCO1 proteins localize to lysosomes and
autophagosomes, particularly near the Golgi complex in
the perinuclear area (Figure 6). Behrends et al. found that
FYCO1 associates with two microtubule motor proteins,
kinesin (KIF) 5B and KIF23.37 Interestingly, depletion of
KIF5B leads to perinuclear accumulation of autophago-
somes, allowing Behrends et al. to propose that KIF5B links
FYCO1-positive autophagosomes tomicrotubules to main-
tain cortical localization.38 Behrends et al. also showed that
C7orf28A associates with FYCO1. C7orf28A depletion led
to an increase in autophagosomenumber without blocking
autophagosomal flux.37 Thus, FYCO1 seems to function as
a platform for assembly of vesicle fusion and trafficking
factors.
The high frequency of frameshift, splice, and nonsense
mutations and the recessive inheritance pattern seen in
the families suggest that arCC in these families results
from loss of FYCO1 function. Loss of functional FYCO1836 The American Journal of Human Genetics 88, 827–838, June 10,could lead to arCC through a variety of mechanisms.
Autophagy is important for degradation of aggregated mis-
folded proteins, and accumulation of protein aggregates is
a classic mechanism for light scattering and loss of lens
transparency. It is also possible that loss of FYCO1 inhibits
transport of autophagosomes from the perinuclear area
to the periphery and leads to an accumulation of large
numbers of vesicles andhence loss of transparency. Perhaps
most intriguing is the possibility that loss of FYCO1 activity
inhibits the organelle degradation that is an integral part
of differentiation of epithelial cells into lens fiber cells.
This would help to explain the specific effect of the
absence of functional FYCO1 on the lens even though it is
widely expressed in the body. In any event, identification
of FYCO1 as a cause of congenital cataracts suggests that
autophagy is critically important for lens transparency.
In summary, we report localization of an arCC locus in
12 families of Pakistani origin and one Arab Israeli family
to a 3.5 cM (12 Mb) chromosomal region, 3p21-p22, and
identification of pathogenic mutations in FYCO1, which
has been shown to affect intracellular transport of auto-
phagocytic vesicles. This study provides a new cellular
andmolecular entry point for understanding lens transpar-
ency and human cataracts and because of the frequency of
FYCO1 mutations in the Pakistani population might be
useful in genetic diagnosis and eventually better cataract
treatment or prevention.Supplemental Data
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